FDA grants RMAT designation to Enlivex's Allocetra for knee OA

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. USO
8. LMT
9. TLT
10. AMZN

Go back to FDA grants RMAT designation to Enlivex's Allocetra for knee OA
Enliven Marketing Technologies Corporation (NASDAQ: ENLV) Delayed: 0.73 -0.08 (9.88%)
Previous Close $0.81    52 Week High $0.94 
Open $0.82    52 Week Low $0.47 
Day High $0.85    P/E N/A 
Day Low $0.64    EPS $-0.11 
Volume 767,697